Aurora Cannabis (TSE:ACB – Free Report) had its price objective trimmed by Jefferies Financial Group from C$6.12 to C$4.95 in a research report released on Tuesday, BayStreet.CA reports. The brokerage currently has a hold rating on the stock.
Other analysts have also recently issued research reports about the stock. CIBC lowered their target price on shares of Aurora Cannabis to C$6.00 and set a neutral rating on the stock in a research note on Wednesday, February 21st. Canaccord Genuity Group raised shares of Aurora Cannabis from a hold rating to a buy rating and set a C$0.80 target price on the stock in a research note on Friday, February 9th.
Read Our Latest Analysis on Aurora Cannabis
Aurora Cannabis Stock Up 3.2 %
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
- Five stocks we like better than Aurora Cannabis
- The How and Why of Investing in Gold Stocks
- Autozone stock price is still in the rally zone
- 3 Fintech Stocks With Good 2021 Prospects
- 2 penny stocks insiders are buying
- Want to Profit on the Downtrend? Downtrends, Explained.
- New highs are coming for Lowe’s stock despite mixed results
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.